Evidence map›Paper›PMID 42108233›Full record

ArticleAnimal genetics2026

Genetic Evidence of a Recent Decline and Crossbreed Distribution of TRPV4 c.1024G>T Variant in Domestic Cats.

Hisashi Ukawa, Ayako Akashi, Hinako Hayashi, Saaya Hiyoshi-Kanemoto, Haruka Onishi, Kai Ataka, Yuki Matsumoto

Abstract read
In one paragraph

Article in Animal genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hisashi UkawaGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
Ayako AkashiGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
Hinako HayashiGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
Saaya Hiyoshi-KanemotoResearch and Development Section, Anicom Specialty Medical Institute Inc., Yokohama, Kanagawa, Japan.
Haruka OnishiGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
Kai AtakaGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
Yuki MatsumotoGenetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-9143-3498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The folded ear phenotype of Scottish Fold cats is associated with an autosomal dominant TRPV4 variant (c.1024G>T) linked to osteochondrodysplasia. Although genetic testing has been implemented to guide breeding, empirical evidence of its impact on allele frequency remains limited, and crossbreed investigations are lacking. Here, we evaluated longitudinal changes in TRPV4 c.1024G>T allele frequencies in Scottish Folds and surveyed the variant in 8610 cats from 14 breeds in Japan. Overall, between 2017 and 2024, the proportion of homozygous cats significantly declined (from 14.2% to 1.9%, p < 0.001), whereas the frequency of heterozygous cats remained stable (39.3% vs. 51.5%, p > 0.74). The variant was identified primarily in Scottish Folds but was also detected in American Curls, Norwegian Forest Cats, Munchkins, and Minuets. Taken together, our results highlight that integrating TRPV4 c.1024G>T genotyping into breeding programs can effectively reduce the prevalence of this hereditary disorder, and they warrant the expansion of genetic testing to additional breeds.

Indexed as

Cat DiseasesOsteochondrodysplasiasTRPV Cation ChannelsAnimalsBreedingCatsFemaleGene FrequencyJapanPhenotypeScotlandTRPV Cation Channelsbreed‐wide distributiondomestic catfeline geneticsgenetic testingosteochondrodysplasiaTRPV4

Identifiers

PMID42108233
PMCPMC13158167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.